Report of the GUDID Clinically Relevant Size (CRS) Work Group

By AHRMM

Related Resources

Advisory
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose…
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Advisory
The FDA UDI ruling has finally arrived - the proposed rule has published.
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Letter/Comment
An announcement of the Final Rule issued by the IRS.